COMMUNIQUÉS West-GlobeNewswire

WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Care

01/05/2024 - 15:00

Personify Health clients will now have integrated access to WeightWatchers for Business’s full-spectrum weight health platform NEW YORK and PROVIDENCE, R.I., May 01, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW [...]

SFWJ/MedCana Reacts to US DEA's Rescheduling of Marijuana

01/05/2024 - 15:00

AUSTIN, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SFWJ, doing business as MedCana, a holding company focused in the cannabis and agricultural technology sectors, joins the cannabis industry in acknowledging a [...]

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

01/05/2024 - 14:47

Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 [...]

Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million

01/05/2024 - 14:45

Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from exercise of three-year warrants issued in offering AUSTIN, Texas, May 01, 2024 ( [...]

SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level

01/05/2024 - 14:35

- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential – - 100% Overall Response Rate in Patients [...]

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

01/05/2024 - 14:31

The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearance MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical [...]

Novo Nordisk A/S - share repurchase programme

01/05/2024 - 14:30

Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

01/05/2024 - 14:30

MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]

Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

01/05/2024 - 14:30

Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and increased the expression of a biomarker [...]

Cepham’s Luteye Centers on Cellular Senescence to Protect Aging Eyes

01/05/2024 - 14:30

SOMERSET, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- In alignment with Healthy Vision Month in May, Cepham , a leader in Ayurvedic nutraceutical ingredients, announces the launch of Luteye, a branded ingredient that [...]

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)

01/05/2024 - 14:30

Company on track to commence Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) before year end Carlsbad, CA, May 01, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“ [...]

Alpha Tau to Participate in May Investor Conferences

01/05/2024 - 14:30

JERUSALEM, May 01, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that [...]

Yield10 Bioscience Announces 1-for-24 Reverse Stock Split

01/05/2024 - 14:30

WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that it will effect a 1-for-24 reverse stock split [...]

Bionet America, Inc. Launches New Brio XVet Multiparameter Veterinary Monitors

01/05/2024 - 14:10

Next-generation surgical monitors enhance safety and convenience for veterinary care TUSTIN, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Bionet America, Inc. today announced the launch of the new Brio XVet series, a [...]

Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives

01/05/2024 - 14:05

Acquire cell therapy manufacturing facility with clinical and commercial capabilities Further ExacTcell platform for additional clinical trials based on successful completion of POC Highlight full year financial results [...]

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

01/05/2024 - 14:04

ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the first [...]

Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

01/05/2024 - 14:01

BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership [...]

Goodness Growth Provides CREAM & Fire Updates

01/05/2024 - 14:01

– Josh Rosen to shed Interim title and become Chief Executive Officer; Company provides other key personnel updates – – Company receives a short-term extension of the maturity date on its credit facility – – Company [...]

Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity

01/05/2024 - 14:00

Prioritization of Peak’s ADC cancer therapeutic platform technology and Akari’s PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic disease Akari Therapeutics announces leadership changes in separate Akari [...]